| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 03/05/2019 | 22h36 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 26/04/2019 | 22h53 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h58 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h53 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h52 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 17h50 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 22h16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 15h28 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 15h01 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 18/04/2019 | 08h00 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, In... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 17/04/2019 | 21h27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 17/04/2019 | 21h25 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 20/03/2019 | 22h06 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 21h42 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 13h35 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 12h20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 12h20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 12h00 | GlobeNewswire Inc. | OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 12/03/2019 | 14h28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 07/03/2019 | 22h41 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |